Liangxing Wang

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Chronic Obstructive Pulmonary Disease

Transcription Factor

Small Cell Lung Cancer

Peritoneal Dialysis

Top Venues

Molecular carcinogenesis

Computational and mathematical methods in medicine

Journal of healthcare engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Lingyan Ye, Guifei Yao, Shuang-Xiang Lin, Yicheng Fang, Xi Chen, Liangxing Wang, Su Su He
The Investigation of Pulmonary Function Changes of COVID-19 Patients in Three Months. Journal of healthcare engineering 2022 (2022)
Yefei Zhu, Shuang-Xiang Lin, Yueping Wang, Bingxiao Shen, Ling Lin, Liangxing Wang, Su Su He
Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World. Computational and mathematical methods in medicine 2021 (2021)
Lingyuan Xu, Sensen Qiu, Lehe Yang, Haitang Xu, Xu Liu, Shiqian Fan, Ri Cui, Weitao Fu, Chengguang Zhao, Liqun Shen, Liangxing Wang, Xiaoying Huang
Aminocyanopyridines as anti-lung cancer agents by inhibiting the STAT3 pathway. Molecular carcinogenesis 58 (8) (2019)
Yangyang Fu, Lihuang Su, Mengsi Cai, Boyang Yao, Sisi Xiao, Qinlian He, Le Xu, Lehe Yang, Chengguang Zhao, Tingting Wan, Lianyou Shao, Liangxing Wang, Xiaoying Huang
Downregulation of CPA4 inhibits non small-cell lung cancer growth by suppressing the AKT/c-MYC pathway. Molecular carcinogenesis 58 (11) (2019)